COMPANY PROFILE

FineHeart

Explore full profile

A French medical device company focused on creating innovative technologies in the cardiovascular space

Pessac, FranceFounded 2010Biotech & Life Sciences

Valuation $100–250M Last recorded · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About FineHeart

Developer of implantable cardiac devices designed to treat cardiovascular diseases. The company's device is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart's innate contractility, enabling patients to restore normal cardiac output and allow heart failure patients to return to a normal quality of life.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2010
Headquarters: Pessac, France
Employees: 87
Open positions: None listed
Dealroom signal: 79.7/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Telecommunications, Biotechnology, Cardiology and cardiovascular, EIC, EIC Fund, biotech medtech and e-health, Observatoire Deeptech
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

9 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Jan 2026	$39M	$154M	Groupe Pasteur Mutualité · NACo · EIC Fund · Irdi Capital Investissement	↗
GRANTOther financing	Dec 2024	$825K	—	European Regional Development Fund	↗

Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Growth	Margin
2026	—	—
2025	—	—
2024	—	—
2023	—	—
2022	—	—
2021	—	—
2020	—	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

FineHeart website traffic

Latest recorded traffic for FineHeart is 480 monthly website visits, down 31.4% over the last three months. FineHeart's team grew 1.2% over the past year.

Latest monthly visits480 3-month web change-31.4% 1-year team growth+1.2%

Monthly website visitsJun 2015–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OSOsivaxA company developing "universal" vaccines able to prevent highly-mutating respiratory viral infections	Lyon, France	Operational	60	$79M	$44M
COCorWaveCorWave develops innovative implantable blood pumps based on a breakthrough membrane technology	Clichy, France	Operational
ABAbbelightAbbelight develops modular products that may adapt to any microscope. Single-molecule localization microscopy uses consumables, hardware, and software	Cachan, France	Operational
ATAenitis TechnologiesDeveloping a cell treatment device	Paris, France	Operational
PKPKvitalityDeveloping a line of wearable trackers with the ability to analyze key physiological markers by simply testing the skin rather than analyzing blood samples	Paris, France	Operational
OROrixhaDeveloping the LV4C (Liquid Ventilation for Cooling) medical device to almost immediately protect the vital organs, in particular the brain and heart	Saint-Cyr-au-Mont-d'Or, France	Operational
BOBOYDSenseBOYDSense - Health monitoring made simple powered by breath	Toulouse, France	Operational
ANAntabioAntabio is a clinical-stage biopharmaceutical company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO	Labège, France	Operational